Trenton, NJ - According to Daniel J. Munoz of NJBIZ, "The New Jersey Economic Development Authority said it approved 161 businesses last year looking to invest dollars in 32 startups via the Angel Investor Tax Credit program—an incentive aimed at enticing financiers to invest into otherwise potentially risky New Jersey enterprises."
Trenton, NJ - According to an interview with Beth Noveck, "The innovation office is designed to do two things: first, to think about how we foster an innovation economy in New Jersey and, second, how we bring innovation inside the state and find new ways of working that actually involve engaging with citizens and data to become more effective at solving problems. So thinking about the regulation of technology, thinking about the impact of technology on the future of work and thinking about how we use technology to promote economic development."
Washington DC - According to Joe Kennedy in The Hill, "The signature accomplishment of President Trump’s first term in office — the Tax Cuts and Jobs Act of 2017 — was a mixed bag for America’s long-term growth. It made U.S. companies more competitive by lowering the corporate income tax rate and moving the country toward a so-called “territorial” tax system that calculates how much firms owe based only on their domestic earnings. But while a strategic rationale for the corporate tax cut was to boost the kind of business investment that drives productivity, it failed to increase the value of the research and development tax credit, and it eliminated firms’ ability to write off research expenses in the first year starting in 2022, meaning companies conducting R&D will pay more taxes, not less. The net effect will be a nearly $8 billion increase in the after-tax cost of R&D."
Ne Brunswick, NJ - According to the Chloe Tai, "Jonathan Moreno, a University of Pennsylvania professor, discussed the topic of gene editing and bioethics as part of the Science and Politics Workshop on Feb. 21. The event was hosted by the Eagleton Institute of Politics. As the lead speaker, Moreno engaged the audience on the topic of gene editing. Two other professors, T. Patrick Hill, associate professor at Edward J. Bloustein School of Planning and Public Policy, and Wise Young, distinguished professor in the Department of Neuroscience, were also asked to share their expertise. The event was open to Rutgers graduate students, post-doctoral fellows and faculty and staff."
Trenton, NJ - According to RIO-NJ, "Gunjan Doshi, the chair of the state’s Commission on Science, Innovation and Technology, was thrilled when he heard the news. Included in the budget proposal Gov. Phil Murphy announced Tuesday was a substantial increase in funding for CSIT. Murphy, who has pushed STEM and innovation since the campaign trail, is proposing to increase funding allocated to CSIT to $3 million, up from $1 million last year."
Columbus, OH - According to Ellen Marrison of SSTI, "Proving that innovation is appealing to states regardless of their size or political leanings, new initiatives in both Democratic and Republican states, as well as large states like California and small states like Vermont, are driving innovation agendas into action in areas ranging from clean energy and aid for students and colleges, to new venture capital investments and bond financing to support business collaborations with higher education to help translate cutting-edge research into products and companies. It is important to note that these new initiatives are in addition to important work that is already occurring in many states. SSTI continues to bring you news of these actions as governors, legislatures, and economic development organizations capitalize on proven programs to build out their innovation economies, with several examples provided here."
Gunjan Doshi, the chair of the state’s Commission on Science, Innovation and Technology, was thrilled when he heard the news. Included in the budget proposal Gov. Phil Murphy announced Tuesday was a substantial increase in funding for CSIT. Murphy, who has pushed STEM and innovation since the campaign trail, is proposing to increase funding allocated to CSIT to $3 million, up from $1 million last year.
“Gov. Murphy has positioned CSIT as a hub of support for the state’s innovation sector, and his proposed budget confirms his continued commitment to a bustling innovation economy ripe with opportunity,” Doshi said. “We thank the governor for this proposed increase in funding, which will enable us to expand our efforts to promote the state as a home for academic and industry research, and as fertile ground for entrepreneurs and young companies seeking top talent.” Please read more here.
Science in the service of humanity: Princeton joins Rutgers, NJIT to advance health-related innovations
Princeton faculty and student researchers make many discoveries that have the potential to address cancer, infectious disease, autism and other development disorders, and other medical, behavioral and health challenges. Now, a collaboration with Rutgers University and the New Jersey Institute of Technology is making it easier and faster for Princeton’s medical and health-related research to reach patients and the community. The collaboration, known as the New Jersey Alliance for Clinical and Translational Science (NJ ACTS), began in 2019 and is funded by a $29 million grant from the National Institutes of Health to speed the translation of research into innovations that can lead to improvements in patient and public health. Please read more here.
South Jersey Tech Park at Rowan University company RelGelTec and co-founder Tony Lowman have been recognized as a top 10 MedTech startup. RelGelTec is developing the next generation of spinal implants for lower back pain and degenerative disc disease. Please read more here.
From New Jersey Business
Governor’s STEM Scholars, an innovative public-private partnership developed by the Research & Development Council of New Jersey to bolster the education and career pipeline in the state, recently held its annual “STEM in Business & Industry Symposium” at the New Jersey Institute of Technology (NJIT). The 95 pre-selected scholars, grades 10 through the doctoral level, had the opportunity to interact with thought leaders representing: Avantor, BASF, Becton Dickinson, Bristol-Myers Squibb, ExxonMobil, Hackensack Meridian Health, Integra LifeSciences, Janssen Pharmaceutical Companies of Johnson & Johnson, Johnson & Johnson, Merck, Nokia Bell Labs, Novartis, and Siemens. Please read more here.
Princeton accelerates innovation through funding of six technologies with potential for societal impact
The projects address a range of societal challenges, from new treatments for cancer, hepatitis B and obesity, to pain-free intravenous injections and low-cost water purification. The funding, administered by the Office of the Dean for Research, supports proof-of-concept research, prototypes, or other studies to bring fundamental discoveries to the point where they can be developed through a spin-out company, established firm or other entity. “Princeton’s faculty and their research teams are making discoveries that have the potential to make a real difference in everyday lives,” said Rodney Priestley, Princeton’s vice dean for innovation. “Through the IP Accelerator Fund, Princeton is identifying some of the most promising technologies and giving them the extra push needed to bring these technologies to the public where they can meet needs in health care, the environment and other sectors.” Please read more here.
From NJTV News
International experts are elevating warnings about the spread of the coronavirus, as Japan reports the first two deaths from passengers quarantined on the Diamond Princess cruise liner. It’s speeding up the race to stop the spread of the infection. And though the CDC reports no confirmed cases here in New Jersey, Michael Hill reports state researchers at Rutgers University might have found the key to fighting it. Please read more here.
From New Jersey Business
Enterprises that are truly capitalizing on intelligent automation (IA) solutions are—in some cases—achieving ROI of 200% or more, and the impact of IA on reducing jobs is highly exaggerated, so enterprises should not view IA’s primary benefit as being headcount reduction. These and other insights in research from Everest Group indicate that enterprises have generated the most cost benefits from IA via additional capacity created by productivity improvements and with minimal layoffs. Everest Group reports that the key drivers for IA adoption continue to be operational effectiveness and enhanced employee and customer satisfaction. Please read more here.
As part of SpaceX’s CRS-19 resupply mission to the International Space Station (ISS) launched Dec. 5, researchers from NASA, New Jersey Institute of Technology (NJIT) and New York University (NYU) are set to begin a new scientific investigation to explore how a group of microscopic particles considered key “building blocks” for materials and products here on Earth, known as colloidal particles, behave and form in zero-gravity. The team’s experimental payload of colloidal samples, which officially docked at the station Dec. 8, will be used to study for the first time what happens when colloidal particles are exposed to temperature changes in the absence of gravity under spaceflight conditions during a series of experiments to be conducted later this year, titled “Advanced Colloids Experiment (Temperature controlled) – ACE-T11.” Please read more here.
Dean Paranicas, CEO and president of the HealthCare Institute of New Jersey, isn’t just another state trade organization leader. Given that at least 11 of the Top 20 medical technology companies have a presence in New Jersey, representing them — as the HealthCare Institute of New Jersey does — means giving a voice to a big part of one of the country’s most vibrant industries. And he’s got a lot to say about why it’s worth paying attention to some of the revolutionary technology coming out of the Garden State’s health care sector. Please read more here.
Do not miss a single innovative moment and sign up for our newsletter!